Abstract
The excellent meta-analysis by Ryan Zarychanski and associates demonstrated that the use of erythropoietin-receptor agonists in critically ill patients does not improve clinically important outcomes.[1][1] Interestingly, the potential drug interaction with corticosteroids was not considered in the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
